Christoph Hennersperger

Christoph Hennersperger
2015/16

Christoph, upon completion of the 2015/16 program, partnered with fellow graduate and Cardiothoracics teammate, Fionn Lahart, to cofound OneProjects, an innovative medical device start-up established to revolutionise the treatment for paroxysmal and persistent Atrial Fibrillation (AFib), which affects millions of people worldwide. As CTO, he has worked closely with Fionn to create VERAFEYE, a digitally connected medical device that will enable clinicians to precisely monitor, verify and improve in-procedural efficiency and efficacy, reduce re-intervention rates and produce significant patient and economic benefits within the AFib space. With the assistance of substantial Enterprise Ireland Commercial Fund seed backing, the company is continuing to build a significant portfolio of IP, with the strategic ambition to spin OneProjects out in Q1 2019 and progress towards commercial market access in 2021.

Our Location

Situated on the prestigious campus of National University of Ireland Galway within the medieval city of Galway, European Capital of Culture in 2020, with equal easy access to the wilderness of Connemara in the west and the European mainland in the east, BioInnovate boasts a superb location.

Our affiliation with Stanford BioDesign has helped us to become one of the world’s leading innovation hubs with an immense debt of gratitude owed to Enterprise Ireland for both their financial and professional support in helping BioInnovate grow.

Contact Us Today
BioInnovate Ireland Block E
National University of Ireland Galway,
Ireland +353 (0)91 492 646